GO:0051895 negative regulation of focal adhesion assembly: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051895 describes any process that stops, prevents, or reduces the frequency, rate or extent of focal adhesion assembly, the establishment and maturation of focal adhesions.
• Focal adhesions are integrin-based, actin-linked adhesions that connect the extracellular matrix to the cytoskeleton and serve as signaling hubs; their negative regulation controls cell migration, invasion and tissue architecture.
• Key molecular brakes include tyrosine phosphorylation events such as Cas phosphorylation, distinct cortactin phospho-forms, ARF1-dependent trafficking, and SAC1-mediated inactivation of Cdc42.
• Dysregulated negative regulation of focal adhesion assembly contributes to cancer invasion, metastasis and chemoresistance, as shown in triple-negative breast cancer and intrahepatic cholangiocarcinoma models.
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of candidate regulators of focal adhesion assembly in isogenic backgrounds.
• Live-cell imaging of paxillin, vinculin or zyxin together with adhesion turnover assays is the standard readout for quantifying negative regulation of focal adhesion assembly.
Description
Focal adhesions are dynamic, integrin-based structures that physically link the extracellular matrix to the actin cytoskeleton and simultaneously act as signaling platforms that influence cell migration, proliferation and survival. The assembly of these structures is tightly controlled in space and time, and cells must be able to stop or slow focal adhesion assembly to permit adhesion turnover, rear-edge retraction and productive motility. GO:0051895, negative regulation of focal adhesion assembly, captures the biological processes that stop, prevent or reduce the frequency, rate or extent of focal adhesion assembly. Understanding this term is important because focal adhesion dynamics sit at the intersection of normal tissue morphogenesis and pathological processes such as tumor cell invasion and metastasis. For researchers, GO:0051895 provides a precise annotation target when interpreting phosphoproteomic, imaging or CRISPR screening data, and it helps distinguish genuine negative regulators from proteins that merely correlate with adhesion disassembly. Because focal adhesion assembly is a multi-step process involving integrin activation, adaptor recruitment, actin polymerization and actomyosin tension, its negative regulation can occur at several mechanistically distinct nodes. This article summarizes the authoritative definition, the major molecular players, disease links and the experimental methods used to study negative regulation of focal adhesion assembly.
negative regulation of focal adhesion assembly At A Glance
| GO ID | GO:0051895 |
|---|---|
| GO term | negative regulation of focal adhesion assembly |
| Ontology | biological_process |
| Definition | Any process that stops, prevents, or reduces the frequency, rate or extent of focal adhesion assembly, the establishment and maturation of focal adhesions. |
| Synonyms | down regulation of focal adhesion formation; down-regulation of focal adhesion formation; downregulation of focal adhesion formation; inhibition of focal adhesion formation |
| Major function | Restrains the formation and maturation of integrin-based focal adhesions, thereby controlling adhesion turnover, cell migration and signaling output. |
| Biological context | Cell-matrix adhesion, cytoskeletal remodeling, cell motility, invasion and tissue morphogenesis. |
| Representative regulators | Cas, cortactin phospho-forms, ARF1, SAC1/Cdc42 axis, APC/EB1-dependent actin nucleation components. |
| Disease relevance | Cancer invasion and metastasis, chemoresistance, and adhesion-dependent pathologies. |
What Is GO:0051895?
According to the Gene Ontology, GO:0051895 (negative regulation of focal adhesion assembly) is any process that stops, prevents, or reduces the frequency, rate or extent of focal adhesion assembly, where focal adhesion assembly is the establishment and maturation of focal adhesions. In practical terms, this term annotates gene products and pathways that act as brakes on the formation and maturation of integrin-based, actin-linked adhesion sites, rather than on their disassembly per se. Synonyms include down regulation of focal adhesion formation, down-regulation of focal adhesion formation, downregulation of focal adhesion formation and inhibition of focal adhesion formation. The term is a biological_process and is positioned as a negative regulatory child of focal adhesion assembly regulation.
Why Is negative regulation of focal adhesion assembly Important in Cell Biology?
Negative regulation of focal adhesion assembly is important because focal adhesions are not static structures; they must be assembled and disassembled in a coordinated manner for cells to migrate, respond to mechanical cues and maintain tissue integrity. When this negative regulation is lost, cells can form excessive or overly stable adhesions, which impairs migration and can promote invasive or chemoresistant phenotypes in cancer. Conversely, excessive negative regulation can destabilize adhesion and contribute to detachment-related pathologies. Because the process is controlled by phosphorylation, small GTPase signaling and membrane trafficking, it is also a rich source of druggable nodes and CRISPR-validatable targets.
• Controls adhesion turnover, which is required for efficient cell migration and invasion.
• Modulates integrin signaling output and downstream survival and proliferation pathways.
• Contributes to cancer cell invasion and metastasis when dysregulated.
• Influences chemotherapy resistance in triple-negative breast cancer through LOX and adhesion-related mechanisms.
• Provides mechanistic context for semaphorin and vascular morphogenesis signaling that impinges on adhesion.
• Involves small GTPase and trafficking regulators such as ARF1 and Cdc42 that are tractable drug targets.
• Serves as an annotation node for interpreting phosphoproteomic and imaging screens of adhesion dynamics.
• Helps distinguish causal negative regulators from bystander proteins in CRISPR screens.
• Relevant to mechanobiology, where adhesion maturation is tuned by actomyosin tension.
• Supports development of experimental models for adhesion-related diseases using isogenic cell lines.
What Happens During negative regulation of focal adhesion assembly?
Initiation of focal adhesion assembly and the need for a brake
In simple terms: Focal adhesions start to form when integrins grab the matrix and recruit adaptor proteins; cells need a brake to stop this process from running out of control.
Focal adhesion assembly begins with integrin engagement of the extracellular matrix, followed by recruitment of adaptors such as talin, paxillin and vinculin and linkage to actin filaments. This nascent adhesion can either mature into a focal adhesion or turnover, and the balance is set by positive and negative regulators. Negative regulation of focal adhesion assembly (GO:0051895) acts at this early stage to reduce the frequency or rate at which nascent adhesions mature, for example by limiting the availability of components or by promoting disassembly-prone states.
Phosphorylation-dependent control of adhesion components
In simple terms: Adding phosphate groups to adhesion proteins can act like a switch that slows down focal adhesion formation.
Cas phosphorylation regulates focal adhesion assembly, and distinct phospho-forms of cortactin differentially regulate actin polymerization and focal adhesions. These phosphorylation events can change protein-protein interactions, alter actin nucleation, or target components for turnover, thereby reducing the extent of focal adhesion assembly. Because different phospho-forms can have opposite effects, the negative regulation annotated to GO:0051895 is often site-specific and context-dependent.
Small GTPase and trafficking inputs
In simple terms: Small molecular switches and the machinery that moves proteins around inside the cell can put the brakes on focal adhesion formation.
ARF1 regulates adhesion of invasive breast cancer cells through formation of focal adhesions, and SAC1-mediated inactivation of Cdc42 inhibits intrahepatic cholangiocarcinoma cell motility and metastasis. These findings place small GTPase signaling and membrane trafficking upstream of focal adhesion assembly, where they can either promote or restrain adhesion formation depending on context. Negative regulation of focal adhesion assembly therefore includes processes that reduce active Cdc42 or alter ARF1-dependent trafficking to limit adhesion maturation.
Cytoskeletal nucleation and condensate control
In simple terms: The cell can also slow focal adhesion formation by changing how actin filaments are built or by clustering adhesion components into droplets.
EB1 directly regulates APC-mediated actin nucleation, linking microtubule plus-end tracking to actin assembly that feeds into adhesion sites. Adhesion-derived condensates control component availability to regulate adhesion dynamics, providing a physical mechanism by which the local concentration of adhesion proteins can be buffered or sequestered. Together, these mechanisms can reduce the frequency or rate of focal adhesion assembly without necessarily disassembling existing adhesions.
Integration with morphogenetic signaling
In simple terms: Guidance cues that pattern blood vessels and tissues can also tune how tightly cells stick to the matrix.
Semaphorin signaling in vascular morphogenesis influences endothelial adhesion and migration, providing a developmental context in which negative regulation of focal adhesion assembly contributes to proper vessel patterning. This illustrates that GO:0051895 is not only a cell-culture phenomenon but also operates during tissue morphogenesis, where timely adhesion turnover is essential.
Key Genes Involved in GO:0051895 negative regulation of focal adhesion assembly
The following genes and proteins have been experimentally linked to negative regulation of focal adhesion assembly or to the focal adhesion assembly process that this term negatively regulates.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CAS | Phosphorylation regulates focal adhesion assembly | Phospho-mutant and knockout models to test causal role in adhesion turnover |
| CTTN | Distinct phospho-forms differentially regulate actin polymerization and focal adhesions | Phospho-site knock-in to dissect negative versus positive regulation |
| ARF1 | Regulates adhesion of invasive breast cancer cells through focal adhesion formation | Knockout and overexpression in MDA-MB-231 models |
| SAC1 | Mediates Cdc42 inactivation downstream of ZNF191 | Knockout to test effects on motility and metastasis |
| CDC42 | Small GTPase whose inactivation restrains motility and adhesion | Point-mutation and knockout to separate adhesion from migration |
| ZNF191 | Inhibits intrahepatic cholangiocarcinoma motility and metastasis via SAC1-Cdc42 | Overexpression and knockout in cholangiocarcinoma lines |
| LOX | Lysyl oxidase, linked to chemotherapy resistance and adhesion biology in TNBC | Knockout and inhibitor studies in triple-negative breast cancer |
| APC | Actin nucleation regulated by EB1 | Knockout and tagged knock-in to monitor nucleation at adhesion sites |
| EB1 | Directly regulates APC-mediated actin nucleation | Live imaging and knockout to test adhesion assembly rates |
| PXN | Focal adhesion adaptor and standard marker | Tagged knock-in for live-cell adhesion tracking |
| VCL | Focal adhesion adaptor linking integrins to actin | Knockout and knock-in for adhesion maturation assays |
| ZYX | Focal adhesion protein used as a maturation marker | Tagged knock-in for turnover measurements |
| TLN1 | Integrin-activating adaptor in nascent adhesions | Knockout to define assembly initiation |
| ITGB1 | Integrin beta-1 subunit that engages matrix | Point-mutation to alter matrix binding and adhesion assembly |
| SEMA | Semaphorin guidance cues influencing vascular adhesion | Overexpression and knockout in endothelial models |
| PLXN | Plexin receptors for semaphorins | Knockout to test adhesion phenotypes in morphogenesis |
| ACTN | Actin crosslinker in mature adhesions | Knockout and tagged knock-in for maturation studies |
How Is negative regulation of focal adhesion assembly Regulated?
Negative regulation of focal adhesion assembly is itself regulated at multiple levels. Phosphorylation of Cas and cortactin provides reversible, site-specific control of adhesion assembly, with distinct phospho-forms acting as positive or negative inputs. Small GTPase signaling, including Cdc42 inactivation via SAC1 and ARF1-dependent trafficking, can restrain adhesion formation in cancer cells. Adhesion-derived condensates buffer the availability of components, adding a physical layer of regulation that can reduce assembly rates. Developmental cues such as semaphorins further tune adhesion during vascular morphogenesis. Together, these mechanisms allow cells to integrate chemical and mechanical signals into a decision to slow or stop focal adhesion assembly.
negative regulation of focal adhesion assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ZNF191 | Intrahepatic cholangiocarcinoma motility and metastasis | Knockout and overexpression in cholangiocarcinoma cell lines |
| SAC1 | Cdc42 inactivation and metastasis suppression | Knockout with motility and adhesion assays |
| LOX | Triple-negative breast cancer chemoresistance | Knockout and inhibitor treatment in TNBC models |
| ARF1 | Invasive breast cancer adhesion | Knockout and rescue in MDA-MB-231 cells |
| CTTN | Adhesion and actin dynamics in cancer | Phospho-mutant knock-in in cancer cell lines |
Cancer invasion and metastasis
Loss of negative regulation of focal adhesion assembly can stabilize adhesions and promote invasive phenotypes. In intrahepatic cholangiocarcinoma, ZNF191 inhibits motility and metastasis through SAC1-mediated Cdc42 inactivation, linking negative regulation of adhesion to reduced metastatic capacity. In triple-negative breast cancer, targeting lysyl oxidase (LOX) overcomes chemotherapy resistance, and LOX is connected to adhesion biology in these cells. ARF1 regulates adhesion of MDA-MB-231 invasive breast cancer cells through focal adhesion formation, further implicating adhesion assembly control in breast cancer invasion.
Chemoresistance
Adhesion-mediated signaling can contribute to chemotherapy resistance. In triple-negative breast cancer, LOX targeting overcomes chemotherapy resistance, and adhesion-related processes are part of the resistant phenotype. This suggests that negative regulators of focal adhesion assembly may be explored as sensitizing targets, although direct evidence for GO:0051895 in chemoresistance remains an active area of research.
Vascular and developmental disorders
Semaphorin signaling in vascular morphogenesis controls endothelial adhesion and migration, and perturbations in this pathway can affect vessel patterning. Because negative regulation of focal adhesion assembly is required for proper endothelial migration, its dysregulation may contribute to vascular malformations, though specific human disease links require further study.
From negative regulation of focal adhesion assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene a causal negative regulator of focal adhesion assembly? | CRISPR knockout with paxillin or vinculin live imaging |
| Does a specific phosphorylation site on cortactin inhibit adhesion assembly? | Point-mutation knock-in of phospho-null or phospho-mimetic residues |
| How does a disease-associated variant affect adhesion turnover? | Knock-in of the variant into an isogenic cell line |
| Where and when does a regulator localize during adhesion assembly? | Endogenous tagged knock-in with fluorescent tag |
| Does overexpression of a candidate gene reduce adhesion assembly? | Doxycycline-inducible overexpression in cancer cell lines |
| Can loss of a negative regulator increase metastasis in vivo? | Knockout cells in xenograft or tail-vein metastasis models |
How to Study the negative regulation of focal adhesion assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell TIRF imaging | Focal adhesion assembly and turnover rates | Quantifying negative regulation in knockout or knock-in cells |
| Phosphoproteomics | Phosphorylation sites on adhesion proteins | Identifying regulatory phospho-forms of cortactin and Cas |
| CRISPR knockout screening | Genes whose loss increases adhesion assembly | Discovering new negative regulators |
| GTPase activity assay | Cdc42 or ARF1 activation state | Testing SAC1 or ARF1 mechanisms |
| Co-immunoprecipitation | Protein-protein interactions in adhesion complexes | Defining molecular complexes that restrain assembly |
| Migration and invasion assays | Functional consequence of adhesion dysregulation | Linking GO:0051895 to metastasis phenotypes |
| Immunofluorescence | Number and size of focal adhesions | Validating imaging-based hits |
| Western blot | Expression and phosphorylation of candidate proteins | Confirming knockout or knock-in status |
Live-cell imaging of focal adhesion dynamics
Tagged knock-in of paxillin, vinculin or zyxin enables time-lapse imaging of adhesion assembly and turnover. This method directly quantifies the frequency and rate of focal adhesion assembly, which is the readout for GO:0051895. Combining with photoactivation or FRAP allows measurement of component exchange at adhesion sites.
Phosphoproteomics and site-specific mutagenesis
Phosphoproteomic profiling can identify phosphorylation events on Cas, cortactin and other adhesion components that correlate with reduced adhesion assembly. Follow-up point-mutation knock-in of phospho-null or phospho-mimetic residues tests causality for negative regulation.
CRISPR screening and functional genomics
Genome-wide or focused CRISPR knockout screens coupled with adhesion readouts can identify negative regulators of focal adhesion assembly. Hits can be validated individually with imaging and biochemical assays. This approach is particularly useful for discovering new components of GO:0051895.
Biochemical and GTPase activity assays
Small GTPase activity assays for Cdc42 and ARF1, together with co-immunoprecipitation of adhesion complex components, help define the molecular mechanism by which a candidate gene reduces focal adhesion assembly. These assays complement imaging by providing biochemical evidence of pathway engagement.
How CRISPR Can Be Used to Study GO:0051895 negative regulation of focal adhesion assembly
Knockout
CRISPR knockout of candidate genes such as CAS, ARF1 or SAC1 allows testing whether loss of the gene increases focal adhesion assembly, which would support its annotation to GO:0051895. Knockout cells can be analyzed by live-cell imaging of paxillin or vinculin to quantify adhesion number, size and turnover.
Point Mutation
Point-mutation knock-in of phosphorylation sites on cortactin or Cas can distinguish phospho-dependent negative regulation from other functions. For example, phospho-null versus phospho-mimetic mutations can reveal whether a specific site is required to reduce focal adhesion assembly.
Knock-in
Tagged knock-in of endogenous adhesion proteins with fluorescent or affinity tags enables real-time tracking of focal adhesion assembly without overexpression artifacts. Disease-associated variants can also be knocked in to test their impact on adhesion dynamics.
Overexpression
Inducible overexpression of candidate negative regulators such as ZNF191 or SAC1 can test whether increased dosage reduces focal adhesion assembly and cell motility. Overexpression should be validated with rescue experiments to avoid artifacts from supraphysiological levels.
How EDITGENE Supports negative regulation of focal adhesion assembly Research
Researchers studying negative regulation of focal adhesion assembly-related genes often need to determine whether a candidate gene is causally involved in restraining adhesion assembly or is merely correlated with it. EDITGENE provides CRISPR-based cell model services that enable precise, isogenic testing of such hypotheses.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of focal adhesion assembly research.
Frequently Asked Questions About negative regulation of focal adhesion assembly
What is GO:0051895 negative regulation of focal adhesion assembly?
GO:0051895 is a Gene Ontology biological process term defined as any process that stops, prevents, or reduces the frequency, rate or extent of focal adhesion assembly, the establishment and maturation of focal adhesions.
What genes are involved in negative regulation of focal adhesion assembly?
Genes experimentally linked to this process include CAS, CTTN, ARF1, SAC1, CDC42, ZNF191, APC, EB1 and LOX, among others.
How is focal adhesion assembly negatively regulated?
Negative regulation occurs through phosphorylation of adhesion components such as Cas and cortactin, small GTPase signaling including Cdc42 inactivation, ARF1-dependent trafficking, and condensate-mediated buffering of components.
Why is negative regulation of focal adhesion assembly important in cancer?
Loss of negative regulation can stabilize adhesions and promote invasion, metastasis and chemoresistance, as seen in triple-negative breast cancer and intrahepatic cholangiocarcinoma models.
What methods are used to study negative regulation of focal adhesion assembly?
Common methods include live-cell imaging of tagged paxillin or vinculin, phosphoproteomics, CRISPR screens, GTPase activity assays and migration assays.
What is the difference between focal adhesion assembly and its negative regulation?
Focal adhesion assembly is the establishment and maturation of adhesions, while negative regulation (GO:0051895) refers to processes that reduce the frequency, rate or extent of that assembly.
Which proteins are markers of focal adhesions?
Paxillin, vinculin, zyxin and talin are widely used markers of focal adhesions and are commonly tagged for live imaging.
Can CRISPR knockout help identify negative regulators of focal adhesion assembly?
Yes, CRISPR knockout of candidate genes followed by imaging of adhesion dynamics can test whether loss of the gene increases focal adhesion assembly, supporting its role in GO:0051895.
What diseases are linked to dysregulated focal adhesion assembly?
Cancer invasion and metastasis, chemoresistance and vascular morphogenesis defects have been linked to altered focal adhesion dynamics.
How does ARF1 regulate focal adhesion assembly?
ARF1 regulates adhesion of invasive breast cancer cells through formation of focal adhesions, and its manipulation alters adhesion phenotypes.
Conclusion
GO:0051895 negative regulation of focal adhesion assembly is a biologically_process term that captures the brakes on integrin-based adhesion maturation. Experimental evidence implicates phosphorylation events, small GTPase signaling, trafficking and condensate biology in restraining focal adhesion assembly. Dysregulation of this process is linked to cancer invasion, metastasis and chemoresistance, making it a relevant area for mechanistic and translational research. CRISPR-based cell models provide a rigorous way to test causality for candidate regulators of this process.
References
- 1. Kumar S et al.. 2023. Cas phosphorylation regulates focal adhesion assembly.. Elife 12 PMID: 37489578
- 2. Saatci O et al.. 2020. Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer.. Nat Commun 11(1):2416 PMID: 32415208
- 3. Kruchten AE et al.. 2008. Distinct phospho-forms of cortactin differentially regulate actin polymerization and focal adhesions.. Am J Physiol Cell Physiol 295(5):C1113-22 PMID: 18768925
- 4. Bussolino F et al.. 2006. Semaphoring vascular morphogenesis.. Endothelium 13(2):81-91 PMID: 16728327
- 5. Juanes MA et al.. 2020. EB1 Directly Regulates APC-Mediated Actin Nucleation.. Curr Biol 30(23):4763-4772.e8 PMID: 33007249
- 6. Dibus M et al.. 2026. Adhesion-derived condensates control component availability to regulate adhesion dynamics.. Nat Commun 17(1) PMID: 42248878
- 7. Schlienger S et al.. 2015. ARF1 regulates adhesion of MDA-MB-231 invasive breast cancer cells through formation of focal adhesions.. Cell Signal 27(3):403-15 PMID: 25530216
- 8. Cheng C et al.. 2025. ZNF191 inhibits intrahepatic cholangiocarcinoma cell motility and metastasis through SAC1-mediated Cdc42 inactivation.. Int J Biol Macromol 329(Pt 1):147668 PMID: 40962084
